Katzenberger T, Lohr A, Ott M M, Kalla J, Rosenwald A, Müller-Hermelink H K, Ott G
Pathologisches Institut, Universität Würzburg.
Verh Dtsch Ges Pathol. 2000;84:153-61.
In the REAL classification system, follicular lymphomas (FL) were subdivided into three grades depending on the number of blasts (6). In this study, we were interested in defining biological parameters possibly being important in the delineation of subgroups. Between 1990 and 1998, biological and cytogenetic investigations were performed on 91 FL. Clonal aberrations were found in all cases. The tumours were subclassified according to the blast content and the morphology of the centrocytes into 29 FL 1, 33 FL 2, 15 FL 3, and 14 FL 3 with a diffuse large B-cell lymphoma component (FL 3 + DLBL). They were characterised by classical cytogenetics, for their mitotic (MI) and proliferative (PI) indices, and CD10, bcl-2, and p53-expression. In contrast to FL 1 and FL 2, which showed a common genetic background with t(14;18), and only differed by their blast content and MI/PI, FL 3 (with or without associated DLBL) turned out to be an inhomogeneous group. 11 follicular lymphomas (with > 150 blasts/10HPF) still showed maturation to centrocytes. They were positive for CD10 and harboured the t(14;18) in 73%. These cases correspond to a "high grade" variant of centroblastic-centrocytic lymphoma according to the Kiel classification (FL 3a). In 18 cases with a follicular or follicular and diffuse growth pattern, the infiltrate consisted of centroblasts exclusively. These tumours were CD10+ in only 50% and were t(14;18)+ in only 22%. Secretory differentiation (clg+) was found in 44%. They were--with respect to primary and secondary chromosome aberrations--more comparable to a follicular variant of DLBL and hence, correspond to centroblastic lymphoma, follicular or centroblastic lymphoma, follicular and diffuse according to the Kiel classification (FL 3b). By histomorphological, biological and cytogenetic investigations, therefore, FL 3 can be delineated into two different biological subgroups with obviously different transformation pathways.
在REAL分类系统中,滤泡性淋巴瘤(FL)根据母细胞数量分为三个等级(6)。在本研究中,我们感兴趣的是确定可能在亚组划分中起重要作用的生物学参数。1990年至1998年间,对91例FL进行了生物学和细胞遗传学研究。所有病例均发现克隆性异常。根据母细胞含量和中心细胞形态,将肿瘤分为29例FL1、33例FL2、15例FL3和14例伴有弥漫性大B细胞淋巴瘤成分的FL3(FL3+DLBL)。通过经典细胞遗传学、有丝分裂(MI)和增殖(PI)指数以及CD10、bcl-2和p53表达对它们进行了表征。与显示t(14;18)共同遗传背景、仅在母细胞含量和MI/PI上有所不同的FL1和FL2相比,FL3(无论有无相关DLBL)结果是一个异质性群体。11例滤泡性淋巴瘤(每10个高倍视野母细胞>150个)仍显示向中心细胞成熟。它们CD10呈阳性,73%携带t(14;18)。根据 Kiel分类,这些病例对应于中心母细胞-中心细胞淋巴瘤的“高级别”变体(FL3a)。在18例具有滤泡性或滤泡性和弥漫性生长模式的病例中,浸润仅由中心母细胞组成。这些肿瘤仅50%为CD10阳性,仅22%为t(14;18)阳性。44%发现有分泌分化(clg+)。就原发性和继发性染色体异常而言,它们与DLBL的滤泡性变体更具可比性,因此,根据Kiel分类对应于中心母细胞淋巴瘤、滤泡性或中心母细胞淋巴瘤、滤泡性和弥漫性(FL3b)。因此,通过组织形态学、生物学和细胞遗传学研究,FL3可分为两个具有明显不同转化途径的不同生物学亚组。